A 0 1 0 1 O
ratio 2 7 2 7 B-clinical_variable
of 8 10 8 10 I-clinical_variable
pre 11 14 11 14 I-clinical_variable
- 14 15 14 15 I-clinical_variable
bronchodilator 15 29 15 29 I-clinical_variable
FEV1 30 34 30 34 I-clinical_variable
to 35 37 35 37 I-clinical_variable
forced 38 44 38 44 I-clinical_variable
vital 45 50 45 50 I-clinical_variable
capacity 51 59 51 59 I-clinical_variable
( 60 61 60 61 I-clinical_variable
FVC 61 64 61 64 I-clinical_variable
) 64 65 64 65 I-clinical_variable
of 66 68 66 68 O
≤ 69 70 69 70 O
80 71 73 71 73 B-upper_bound
% 73 74 73 74 I-upper_bound
at 75 77 75 77 O
screening 78 87 78 87 O

Exacerbation 0 12 88 100 O
requiring 13 22 101 110 O
treatment 23 32 111 120 O
with 33 37 121 125 O
systemic 38 46 126 134 B-treatment
corticosteroids 47 62 135 150 I-treatment
within 63 69 151 157 O
the 70 73 158 161 O
last 74 78 162 166 B-upper_bound
3 79 80 167 168 I-upper_bound
months 81 87 169 175 I-upper_bound

FEV1 0 4 176 180 B-clinical_variable
≥ 5 6 181 182 O
30 7 9 183 185 B-lower_bound
% 9 10 185 186 I-lower_bound
and 11 14 187 190 O
≤ 15 16 191 192 O
79 17 19 193 195 B-upper_bound
% 19 20 195 196 I-upper_bound
( 21 22 197 198 O
post 22 26 198 202 O
- 26 27 202 203 O
bronchodilator 27 41 203 217 O
) 41 42 217 218 O
of 43 45 219 221 O
predicted 46 55 222 231 O
normal 56 62 232 238 O
at 63 65 239 241 O
screening 66 75 242 251 O

History 0 7 252 259 O
of 8 10 260 262 O
lung 11 15 263 267 B-treatment
transplant 16 26 268 278 I-treatment

Individuals 0 11 279 290 O
with 12 16 291 295 O
PiMZ 17 21 296 300 B-chronic_disease
deficiency 22 32 301 311 I-chronic_disease
are 33 36 312 315 O
not 37 40 316 319 O
allowed 41 48 320 327 O
in 49 51 328 330 O
the 52 55 331 334 O
study 56 61 335 340 O

Men 0 3 341 344 B-gender

Upper 0 5 345 350 B-chronic_disease
or 6 8 351 353 I-chronic_disease
lower 9 14 354 359 I-chronic_disease
respiratory 15 26 360 371 I-chronic_disease
tract 27 32 372 377 I-chronic_disease
infection 33 42 378 387 I-chronic_disease
within 43 49 388 394 O
2 50 51 395 396 B-upper_bound
weeks 52 57 397 402 I-upper_bound
prior 58 63 403 408 I-upper_bound
to 64 66 409 411 O
screening 67 76 412 421 O
and 77 80 422 425 O
baseline 81 89 426 434 O
( 90 91 435 436 O
day1 91 95 436 440 O
) 95 96 440 441 O

Women 0 5 442 447 B-gender
of 6 8 448 450 O
childbearing 9 21 451 463 O
potential 22 31 464 473 O

Women 0 5 474 479 B-gender
who 6 9 480 483 O
are 10 13 484 487 B-pregnancy
pregnant 14 22 488 496 I-pregnancy

aged 0 4 497 501 B-age
18 5 7 502 504 B-lower_bound
through 8 15 505 512 O
80 16 18 513 515 B-upper_bound
years 19 24 516 521 I-upper_bound
at 25 27 522 524 O
the 28 31 525 528 O
time 32 36 529 533 O
of 37 39 534 536 O
consent 40 47 537 544 O

have 0 4 545 549 O
smoked 5 11 550 556 O
within 12 18 557 563 O
the 19 22 564 567 O
last 23 27 568 572 B-upper_bound
3 28 29 573 574 I-upper_bound
months 30 36 575 581 I-upper_bound

liver 0 5 582 587 B-treatment
transplant 6 16 588 598 I-treatment

men 0 3 599 602 B-gender
who 4 7 603 606 O
are 8 11 607 610 O
sexually 12 20 611 619 O
active 21 27 620 626 O
must 28 32 627 631 B-contraception_consent
agree 33 38 632 637 I-contraception_consent
to 39 41 638 640 I-contraception_consent
use 42 45 641 644 I-contraception_consent
an 46 48 645 647 I-contraception_consent
adequate 49 57 648 656 I-contraception_consent
method 58 64 657 663 I-contraception_consent
of 65 67 664 666 I-contraception_consent
contraception 68 81 667 680 I-contraception_consent
( 82 83 681 682 O
oral 83 87 682 686 B-treatment
contraceptives 88 102 687 701 I-treatment
, 102 103 701 702 O
depot 104 109 703 708 B-treatment
progesterone 110 122 709 721 I-treatment
, 122 123 721 722 O
condom 124 130 723 729 B-treatment
plus 131 135 730 734 I-treatment
spermicidal 136 147 735 746 I-treatment
, 147 148 746 747 O
or 149 151 748 750 O
IUD 152 155 751 754 B-treatment
) 155 156 754 755 O
during 157 163 756 762 O
the 164 167 763 766 O
study 168 173 767 772 O
and 174 177 773 776 O
for 178 181 777 780 O
1 182 183 781 782 B-upper_bound
month 184 189 783 788 I-upper_bound
after 190 195 789 794 O
the 196 199 795 798 O
final 200 205 799 804 O
dose 206 210 805 809 O
of 211 213 810 812 O
study 214 219 813 818 O
drug 220 224 819 823 O

women 0 5 824 829 B-gender

